Interview with Philippe Ranty, Managing Director, Actavis France
Most players entered the generic pharmaceutical industry in France in the late 1990s into the 2000s yet Actavis decided to enter much later – in late 2007 – through an…
Address: 10 rue d’Arcueil – BP 90233 94528 Rungis Cedex,France
Tel: +33 (0)1.45.60.25.00
Abbott is among the ten largest groups worldwide working in the service of health. Our mission is to discover new treatments, new technologies and new ways to care for patients.
Our story began there more than 100 years thanks to a major scientific innovation. Today, our 72 000 employees in the world, still share the same values with the same goal: Advancing Science for Health.
Key figures 2008:
National Staff: 1000 persons
Turnover: 680.9 million euros.
Pharmaceuticals
Primary Care:
Infectious Disease
Cardiovascular
Metabolism / Obesity
Specialty Care:
HIV / Virology
Immunology
Anesthesia / pain
Neonatology
Medical Products
Laboratory Diagnosis
Molecular Diagnostics
Blood Diagnosis
Medical Nutrition
Diabetes
Most players entered the generic pharmaceutical industry in France in the late 1990s into the 2000s yet Actavis decided to enter much later – in late 2007 – through an…
CIP and GERS have very unique relationships with the pharmaceutical industry. Could you elaborate on the role of these two bodies? Club Inter-pharmaceutique (CIP) is a professional association created in…
As a majority of our readers are American that may be used to a different model of clusters can you explain the unique characteristics of the pôles de compétitivité? The…
Aricept has been a very effective blockbuster for the group as a whole and the loss of exclusivity affects not only France but entire company. How is Eisai in France…
There is a lot of change occurring in the French pharmaceutical industry at the moment and this is no different for Boehringer Ingelheim. Just last September you moved into these…
As president of LEEM, what will be your legacy and what legacy would you like to instill in the organization? A legacy of re-industrialization in the French pharmaceutical and health…
Roche has a long history in France and currently enjoys a higher position than its worldwide ranking. Can you elaborate on the importance of this market for the group overall?…
Do you feel the industry has changed more over the past ten years than over the entire 40 years before? It’s an optical illusion. People always have had the feelings…
As the G5 brings together five very different companies – Ipsen, LFB, Pierre Fabre, Sanofi-Aventis, Servier – could you explain the origin behind the creation and the purpose of the…
You’ve been at the head of AstraZeneca France for 7 years through during which time there has been a lot of M&A activity in the industry as well as a…
Generic drugs were a very late arrival for the French market in comparison with other European markets and healthcare systems on a par with the French one. Today the gap…
Throughout your prolific career in the pharmaceutical industry, what would you describe have been the major changes in the French pharmaceutical market and to what extent has France kept up?…
See our Cookie Privacy Policy Here
